Shree Satyabhama Medical Center Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 18-12-2024
- Paid Up Capital ₹ 5.00 M
as on 18-12-2024
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.95 Cr
as on 18-12-2024
- Revenue 41.27%
(FY 2022)
- Profit -19.65%
(FY 2022)
- Ebitda 14.13%
(FY 2022)
- Net Worth 60.34%
(FY 2022)
- Total Assets 0.34%
(FY 2022)
About Shree Satyabhama Medical Center
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹1.95 Cr.
Mohit Mittal and Mitsu Mittal serve as directors at the Company.
- CIN/LLPIN
U85110DL2006PTC145159
- Company No.
145159
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jan 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shree Satyabhama Medical Center?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mitsu Mittal ![]() | Director | 17-Mar-2014 | Current |
Mohit Mittal ![]() | Director | 15-Dec-2010 | Current |
Financial Performance of Shree Satyabhama Medical Center.
Shree Satyabhama Medical Center Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 41.27% increase. The company also saw a substantial fall in profitability, with a 19.65% decrease in profit. The company's net worth Soared by an impressive increase of 60.34%.
![Revenue Growth Graph](/Images/financial/revenue-growth.webp)
![Profit Loss Graph](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Satyabhama Medical Center?
In 2021, Shree Satyabhama Medical Center had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
![Shareholding Indiacator](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 11 Jan 2016 | ₹1.95 Cr | Open |
How Many Employees Work at Shree Satyabhama Medical Center?
Unlock and access historical data on people associated with Shree Satyabhama Medical Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
![Employee Graph](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Valuation-Graph](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Shree Satyabhama Medical Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Satyabhama Medical Center's trajectory.
Rating
![Rating-Graph](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert-Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.